- Highly successful partnership continues with fast-growing provider of attractively-priced prosthetics for most leading implant systems
- Straumann to consolidate Medentika fully in its 2017 financial statements
Basel, 30 November 2016: Straumann has signed an agreement with the other shareholders of Medentika to obtain a controlling interest in Medentika. At the same time Straumann is acquiring Medentika’s share of their jointly-held distribution business in Germany, Medentika’s biggest market.
The two companies became partners three years ago, when Straumann purchased a 51% non-controlling stake in Medentika. The original agreement foresaw Straumann gaining a controlling interest in November 2017 but the two companies have agreed to bring this forward in order to deepen their relationship and to add organizational clarity to their common activities.
With effect of 1 January 2017, Straumann will therefore fully consolidate Medentika’s financial statements and balance sheet. The ownership structure of Medentika – and Straumann’s stake – remain unchanged and the founding shareholders will continue to have an active role in the company.
The partnership between the two companies has been highly successful: through its Instradent platform, Straumann has assisted Medentika’s international expansion and has made a significant contribution to the company’s development and sustainable growth. For its part, Medentika has contributed significantly to Straumann’s strategic goals of providing comprehensive solutions to dental labs and becoming a global leader in the ‘value’ segment of the tooth-replacement market.